Inhibitors of cullin-RING E3 ubiquitin ligase 4 with antitumor potential
Open Access
- 18 February 2021
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 118 (8)
- https://doi.org/10.1073/pnas.2007328118
Abstract
Cullin-RING (really intersting new gene) E3 ubiquitin ligases (CRLs) are the largest E3 family and direct numerous protein substrates for proteasomal degradation, thereby impacting a myriad of physiological and pathological processes including cancer. To date, there are no reported small-molecule inhibitors of the catalytic activity of CRLs. Here, we describe high-throughput screening and medicinal chemistry optimization efforts that led to the identification of two compounds, 33-11 and KH-4-43, which inhibit E3 CRL4 and exhibit antitumor potential. These compounds bind to CRL4’s core catalytic complex, inhibit CRL4-mediated ubiquitination, and cause stabilization of CRL4’s substrate CDT1 in cells. Treatment with 33-11 or KH-4-43 in a panel of 36 tumor cell lines revealed cytotoxicity. The antitumor activity was validated by the ability of the compounds to suppress the growth of human tumor xenografts in mice. Mechanistically, the compounds’ cytotoxicity was linked to aberrant accumulation of CDT1 that is known to trigger apoptosis. Moreover, a subset of tumor cells was found to express cullin4 proteins at levels as much as 70-fold lower than those in other tumor lines. The low-cullin4–expressing tumor cells appeared to exhibit increased sensitivity to 33-11/KH-4-43, raising a provocative hypothesis for the role of low E3 abundance as a cancer vulnerability.Keywords
Funding Information
- HHS | NIH | National Cancer Institute (1R01CA251425-01)
- HHS | NIH | National Institute of General Medical Sciences (R01GM122751)
This publication has 38 references indexed in Scilit:
- From Discovery to Bedside: Targeting the Ubiquitin SystemCell Chemical Biology, 2019
- UBE2G1 governs the destruction of cereblon neomorphic substrateseLife, 2018
- Suramin inhibits cullin-RING E3 ubiquitin ligasesProceedings of the National Academy of Sciences of the United States of America, 2016
- Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligaseNature, 2016
- Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDSNature, 2015
- Microscale thermophoresis quantifies biomolecular interactions under previously challenging conditionsMethods, 2012
- Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysisNature, 2012
- The cullin protein familyGenome Biology, 2011
- Priming and Extending: A UbcH5/Cdc34 E2 Handoff Mechanism for Polyubiquitination on a SCF SubstrateMolecular Cell, 2010
- Function and regulation of cullin–RING ubiquitin ligasesNature Reviews Molecular Cell Biology, 2005